TRELEGY ELLIPTA

This brand name is authorized in Austria, Australia, Brazil, Canada, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States

Active ingredients

The drug TRELEGY ELLIPTA contains a combination of these active pharmaceutical ingredients (APIs):

1 Fluticasone furoate
UNII JS86977WNV - FLUTICASONE FUROATE

Fluticasone furoate is a synthetic trifluorinated corticosteroid that possesses a very high affinity for the glucocorticoid receptor and has a potent anti-inflammatory action.

Read about Fluticasone furoate
2 Umeclidinium
UNII 7AN603V4JV - UMECLIDINIUM BROMIDE

Umeclidinium is a long acting muscarinic receptor antagonist (also referred to as an anticholinergic). It is a quinuclidine derivative that is a muscarinic receptor antagonist with activity across multiple muscarinic cholinergic receptor subtypes. Umeclidinium bromide exerts its bronchodilatory activity by competitively inhibiting the binding of acetylcholine with muscarinic cholinergic receptors on airway smooth muscle.

Read about Umeclidinium
3 Vilanterol
UNII 40AHO2C6DG - VILANTEROL TRIFENATATE

Vilanterol is a selective long-acting, beta2-adrenergic agonist (LABA). The pharmacologic effects of beta2-adrenoceptor agonist active substances, including vilanterol, are at least in part attributable to stimulation of intracellular adenylate cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cyclic AMP). Increased cyclic AMP levels cause relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells.

Read about Vilanterol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
R03AL08 R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AL Adrenergics in combination with anticholinergics
Discover more medicines within R03AL08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 11379X
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 510620020054407, 510620020054507
Country: CA Health Products and Food Branch Identifier(s): 02474522
Country: EE Ravimiamet Identifier(s): 1756425, 1756436, 1756447
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 117123602
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 391529, 406412
Country: FR Base de données publique des médicaments Identifier(s): 63047629
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 349523
Country: HK Department of Health Drug Office Identifier(s): 65911
Country: IE Health Products Regulatory Authority Identifier(s): 24739
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 8257, 8997, 8998
Country: JP 医薬品医療機器総合機構 Identifier(s): 2290804G1022, 2290804G2029, 2290804G3025, 2290804G4021
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1084477, 1084478, 1084479
Country: NL Z-Index G-Standaard, PRK Identifier(s): 149470
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 19806, 22512
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100396029
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W64067001, W64067002, W64067003
Country: SG Health Sciences Authority Identifier(s): 15806P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699522553501, 8699522553525, 8699522553532, 8699522557158, 8699522557165, 8699522557172
Country: US FDA, National Drug Code Identifier(s): 0173-0887, 0173-0893

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.